NCT06882148View on ClinicalTrials.gov

Drug Survival of Target Therapies in Atopic Dermatitis

RecruitingOBSERVATIONAL
Enrollment

1,167

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

October 30, 2026

Study Completion Date

October 30, 2028

Conditions
Atopic Dermatitis
Interventions
DRUG

target therapies (biological drug, small molecules)

describe the drug sruvival rate of the different approved drugs

Trial Locations (1)

00168

RECRUITING

fondazione policlinico universitario agostino gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER